Tructum

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tructum

Property Description
Active ingredient Ketoconazole
Form Tablet (oral), Cream, Shampoo, Gel (topical)
Pharmacological class Azole Antifungal Agent
General purpose Manage fungal and yeast infections
Origin Synthetic (Imidazole derivative)

What is Tructum and What Type of Medicine Is It?

Tructum is a medicinal product whose active substance is Ketoconazole, classified pharmacologically as a synthetic Azole Antifungal Agent. It belongs specifically to the Imidazole derivative group, a class of compounds developed for their potent action against fungi and yeasts. Ketoconazole's primary general purpose is its antimycotic effect, meaning it addresses the source of infections by targeting the responsible organism. As an antifungal agent, Ketoconazole is utilized for various mycotic infections.


Composition, Forms, and Differentiation

The active ingredient in this medicine is Ketoconazole, which is generally formulated as a single-active-ingredient product (monotherapy). Tructum is made available in different dosage forms to suit the infection type: tablets are used for oral (systemic) administration, while creams, shampoos, or gels are intended for topical (external) application on the skin or scalp. The versatility across these various delivery systems is clinically utilized for managing conditions that require both internal medication and direct surface application. This medication is established as a dermatological and systemic antifungal agent. The form dictates the route of administration, allowing the medication to be delivered either to the entire body or concentrated at a localized site of infection.


How Does Tructum Generally Work to Help?

Tructum works by disrupting the life cycle of the invading fungus through a targeted biochemical process. Ketoconazole actively interferes with the synthesis of ergosterol, a vital component necessary for constructing the fungal cell membrane. This disruption compromises the structural integrity of the cell, functioning either to stop the growth of the fungus (fungistatic effect) or, at certain concentrations, to kill the fungal cells outright (fungicidal effect). The overall benefit of this medicine is to prevent the proliferation of pathogenic fungi, allowing the body to clear the infection and resolve the underlying infectious process.

What side effects are possible with Tructum?

Possible Side Effects and Safety Information

Regulatory documents classify the potential side effects of systemic Tructum (Ketoconazole oral tablet) by their frequency and the body system affected. These classifications establish the known safety profile, which differs significantly from the localized effects observed with topical forms (cream, shampoo, gel).

Adverse Reaction Classification (Systemic Use)

Classification Examples of Officially Listed Adverse Reactions
Very Common Abnormal liver function tests, hepatic enzyme increases.
Common Adrenal insufficiency, nausea, vomiting, abdominal pain, pruritus, rash.
Uncommon Headache, dizziness, thrombocytopenia, somnolence, alopecia.
Rare Severe hepatotoxicity (including fatal cases), anaphylactic reactions, gynecomastia.

Serious Safety Considerations

The most serious safety risk documented in regulatory labeling for the oral tablet is severe hepatotoxicity, which includes cases of liver failure. This is often an unpredictable (idiosyncratic) reaction that has been reported both shortly after treatment initiation and later in the course of therapy. Additionally, the drug is officially associated with the potential for adrenal insufficiency due to the suppression of corticosteroid secretion, which may be dose-related.

Population-Specific Constraints

The systemic use is contraindicated in individuals with pre-existing acute or chronic liver disease, reflecting a key safety restriction in regulatory documents. Due to the potential for severe adverse reactions, the official labels recommend that patients receiving the oral tablet be closely monitored with Liver Function Tests (LFTs) before and during the treatment course.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Tructum, which contains Ketoconazole, is primarily associated with the risk of acute liver injury. Regulatory documents emphasize that immediate medical attention must be sought when an overdose is suspected. Prompt recognition of liver injury signs is considered essential.

Documented Manifestations and Severe Outcomes: The official labeling states that overdose may present with symptoms related to hepatocellular and cholestatic liver injury. These clinical manifestations include unusual fatigue, anorexia, nausea, abdominal pain, and the appearance of jaundice (yellowing of the skin or eyes), dark urine, or pale stools. The severity of overdose is high, as serious hepatotoxicity has been documented, including cases with a fatal outcome or requiring liver transplantation.

Mandated Emergency Actions and Management: When an overdose occurs, treatment is symptomatic and supportive, as no specific antidote is known. Emergency management procedures, if required, include gastric lavage or administration of activated charcoal, typically if the ingestion occurred within the first hour. Close patient monitoring is required, including the assessment of blood pressure, fluid, and electrolyte balance. If the patient shows signs of adrenal insufficiency, regulatory procedure dictates the administration of hydrocortisone in conjunction with saline and glucose infusion.

Therapeutic Uses of Tructum

What Tructum Treats: Main Uses and Benefits

Tructum is commonly used for managing conditions presenting with manifestations of fungal or yeast infections, addressing symptoms that create noticeable physiological strain and interfere with daily functioning. This medication is relevant for easing symptomatic discomfort across several therapeutic domains.


Management of Fungal Skin and Scalp Discomfort

This area is applied across domains where additional symptomatic support is needed to address symptoms related to inflammatory or irritative states on the skin and scalp. This includes characteristic manifestations such as scaling, flaking, redness, and persistent itching (pruritus). Tructum is relevant for managing conditions like ringworm, jock itch, seborrheic dermatitis, and Pityriasis Versicolor. Tructum plays a role in managing these symptoms, which may assist with maintaining functional stability and supports general well-being during symptomatic phases.

“The primary goal of this therapy is to address the discomfort and visual signs caused by fungal proliferation, supports maintenance of functional stability.”

Therapy for Severe and Recurrent Infections

Tructum is also used in situations involving certain distressing symptoms of more challenging fungal presentations, including infections that are recurrent or episodic. It is commonly used for systemic conditions such as Blastomycosis and Histoplasmosis, when alternative treatment approaches are appropriate. Applied in contexts marked by increased discomfort or systemic burden, this use provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relevant for managing Pruritus (Itching) and Scaling

Regulatory References

  1. NIH MedlinePlus overview of Ketoconazole

Eligibility and Restrictions for Use

Tructum is a biosimilar to trastuzumab, and is used to treat HER2-overexpressing breast cancer and metastatic HER2-overexpressing gastric or gastroesophageal junction adenocarcinoma. It is only administered to patients whose cancer has been tested and confirmed to be Human Epidermal growth factor Receptor 2 (HER2) positive.


Who Can and Cannot Use Tructum

Patient Population Use Status
Adults with HER2-positive breast or gastric/gastroesophageal junction cancer Generally Permitted (based on specific indication and monitoring)
Individuals with known hypersensitivity to Tructum or its components Contraindicated
Patients with a history of serious heart problems (e.g., severe heart failure) Caution/Contraindicated (requires careful cardiac assessment and monitoring)
Pregnant women Contraindicated (potential risk of severe harm to the fetus)
Nursing mothers Caution (should be used only if benefit justifies potential risk to the newborn)
Children and adolescents (Pediatric Use) Safety and effectiveness not established

All patients considered for Tructum must undergo a thorough cardiac assessment, including an evaluation of their left ventricular ejection fraction (LVEF), before treatment begins and at regular intervals during therapy, due to the risk of cardiac dysfunction.

What should I know about interactions with other medicines?

Tructum Interactions with other medicines and products

Tructum (oral ketoconazole) is a potent inhibitor of the metabolic enzyme Cytochrome P450 3A4 (CYP3A4) and specific drug transporters like P-glycoprotein (P-gp). This interference significantly increases the plasma concentration of co-administered medicines, structuring the product's official interaction profile.


Formal Contraindicated Combinations

The highest-risk interactions are classified as contraindicated due to the potential for life-threatening events from increased drug exposure, including:

Category Prohibited Medicines (Examples)
Cardiotoxicity Risk dofetilide, quinidine, pimozide, cisapride, dronedarone, ranolazine, methadone
Skeletal Muscle Toxicity lovastatin, simvastatin
Ergotism Risk ergotamine, dihydroergotamine
Sedation/Toxicity oral midazolam, triazolam, alprazolam, lurasidone, quetiapine

Administration and Constraint Rules

Interaction rules are also tied to absorption and population status:

  • Acid-Reducing Agents: Oral absorption is pH-dependent. Medicines that reduce stomach acid (e.g., antacids, H2-receptor blockers) must be administered at least two hours after the Tructum dose to avoid a reduction in Tructum's exposure.
  • Alcohol: Consumption of alcoholic beverages is officially advised against during treatment due to the increased risk of hepatotoxicity.
  • Population Note: Oral use is contraindicated in patients with acute or chronic liver disease, and specific combinations (e.g., with colchicine or clarithromycin) are restricted in patients with severe renal impairment.

Mechanism of Action

The mechanism of action involves targeted interference with the biological structures required for fungal sterol synthesis.


Molecular Targeting of Fungal Enzyme Systems

The drug acts within domains involving enzyme-mediated signaling by specifically engaging and inhibiting the fungal enzyme Cytochrome P450 14alpha-demethylase (14alpha-DM or CYP51A1). This molecular blockade inhibits the biosynthesis of ergosterol, the primary sterol of the fungal cell membrane.

Cascade of Cellular and Structural Impairment

This initial molecular event initiates a cascade that leads to structural and functional impairment of the fungal cell. The lack of ergosterol results in the accumulation of toxic precursor sterols (like lanosterol) within the cell membrane. This compromise immediately alters the membrane's fluidity and permeability, impairing critical functions like nutrient transport and osmotic regulation, which ultimately induces cytotoxicity and mitotic arrest.

Mechanism Constraints and Host Interactions

The drug’s primary mechanism of action is focused on fungal cells, but the action's effectiveness is constrained by biological counter-mechanisms, such as the development of fungal drug efflux pumps or mutations in the CYP51A1 gene that reduce the drug's binding affinity. Additionally, the drug possesses the intrinsic mechanistic characteristic of binding to mammalian P450 enzymes involved in the host's steroid synthesis pathways.

Dosage and Administration Information

How to Use Tructum

Usage of Tructum (Ketoconazole) involves specific protocols depending on the chosen route of administration, which is either oral for systemic conditions or topical for localized infections of the skin and scalp. This distinction determines the required formulation, dosing schedule, and associated administration constraints.


Official Administration Protocols

Property Administration Guideline
Route of Administration Oral tablet (systemic) or topical forms (cream, gel, shampoo) for external application.
Standard Adult Oral Dose Typically initiated at 200 mg once daily, which may be increased to 400 mg once daily for systemic fungal infections.
Timing with Meals The oral tablet must be taken with a meal to ensure the active ingredient is properly absorbed into the body.
Dosing Frequency (Topical) Topical forms are generally applied once or twice daily, depending on the formulation and specific condition being addressed.
Course Duration Systemic treatment typically requires a minimum duration of 6 months, while topical courses for cutaneous infections range from 2 to 6 weeks.

Administration Contextual Constraints

Standard protocols involve specific procedural steps for use. For the oral tablet, adherence to timing constraints is necessary; acid-reducing agents like antacids must be administered at least 1 hour before or 2 hours after the Tructum dose to prevent impaired absorption.

In pediatric patients ≥ 2 years, the systemic oral dose is calculated based on body weight, using a range of 3.3 to 6.6 mg/kg/day. For topical administration using the shampoo, the product must remain in contact with the affected area for 3 to 5 minutes prior to rinsing to facilitate the intended application effect. These instructions provide a standardized approach to the administration of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tructum

The following overview summarizes the types of clinical research and studies conducted on the active ingredient in Tructum (Ketoconazole), according to information available from regulatory and scientific sources. This information describes what has been observed in research settings. Study results reflect the specific conditions under which they were conducted and research does not determine whether an individual will respond similarly.

Evidence for Topical Use in Superficial Fungal Infections

This section summarizes the structure of clinical research, including randomized controlled trials (RCTs) and systematic reviews, that have examined the active ingredient's use for localized fungal and yeast infections of the skin and scalp.

Studies for Fungal Skin Conditions (Dermatophytosis)

Research explored the use of the active ingredient for conditions characterized by fluctuating or episodic manifestations like ringworm and athlete's foot. Studies were evaluated in controlled clinical trials that focused on short-term symptom changes. The main outcomes studied involved measuring Clinical Cure (resolution of visible signs) and Mycological Cure (laboratory evidence of fungal eradication). Studies examined patterns observed in relation to combined clinical and mycological outcomes over defined time intervals. Follow-up durations were limited in the primary trials, and comparative evidence is lacking or inconsistent regarding outcomes when compared to other topical treatments.

Studies for Seborrheic Dermatitis

Research exploring short-term symptom changes has been conducted using randomized controlled trials, often designed to include a non-active base (placebo). Outcomes linked to inflammatory or irritative states, specifically scaling, redness, and patient-reported outcomes describing perceived discomfort, were routinely monitored. Findings describe patterns observed related to clinical status over short study periods (2 to 4 weeks). There is limited information for long-term outcomes, such as the assessment of recurrence or relapse after the treatment period is stopped.

Evidence for Oral Use in Systemic Fungal Infections

This section describes the structure of historical and foundational prospective clinical trials that focused on the oral tablet form for severe, non-life-threatening endemic mycoses, specifically including Blastomycosis and Histoplasmosis. The active ingredient was evaluated in research exploring temporary physiological imbalance associated with systemic infections. The trials examined the outcomes across different daily dosages and followed participants for extended time intervals, sometimes up to two years after treatment cessation, to assess recurrence. A key research limitation is that sample sizes were modest for these specific systemic diseases, and evidence is limited for its use in immunosuppressed patients.

Key Studies & References

  1. WHO Model List of Essential Medicines
  2. Ketoconazole (Oral) - MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Tructum (FAQ)

Q: What is the main reason Tructum is prescribed?

A: Tructum is prescribed for two distinct serious health concerns, as noted in official documents. Tructum (Ketoconazole) is described as an antifungal agent used for severe systemic fungal infections and topically for infections of the skin and scalp. In its other form (Trastuzumab), it is used for HER2-overexpressing breast and gastric cancers, following confirmation that the cancer is HER2-positive.


Q: How quickly does Tructum usually start working?

A: The time it takes to see results varies depending on the condition being addressed. For localized topical use, regulatory information indicates that clinical improvement may be seen fairly soon after starting treatment. Regulatory guidelines indicate that the full prescribed course should be completed to address the condition fully, as stopping early may be associated with recurrence.


Q: What should I do if I forget to take Tructum?

A: Official guidelines describe that a missed dose may be taken as soon as it is noticed, provided it is not near the time for the next scheduled dose. Product information states that taking double or extra doses is not recommended. This procedure is generally outlined in the product labeling.


Q: Are there any specific foods or drinks to avoid while using Tructum?

A: Regulatory documents indicate that the oral tablet is to be administered with a meal to support the absorption of the active ingredient. Furthermore, official guidelines describe that consumption of alcoholic beverages is advised against during treatment, which is linked to an increased risk of liver damage.


Q: How long can a person safely take Tructum?

A: The official duration for Tructum treatment depends entirely on the type and severity of the condition. For topical fungal use, treatment is typically 2 to 6 weeks. For systemic fungal infections, the treatment often requires a minimum of 6 months. These durations represent the course length described in official documents, not a statement on a person's absolute safety limit.


Q: What makes Tructum different from other drugs for the same condition?

A: Tructum (Ketoconazole) is classified as an Azole Antifungal. Its mechanism involves specifically inhibiting a fungal enzyme called Cytochrome P450 14alpha-demethylase (14alpha-DM or CYP51A1). This action blocks the production of ergosterol, which is a vital component needed to build the fungal cell membrane, ultimately leading to the death or inhibited growth of the fungus.


Q: Do studies show Tructum is effective for long-term use?

A: Studies on long-term use have been conducted, particularly in systemic fungal trials where follow-up extended for up to two years to assess recurrence. However, official information notes that research regarding long-term outcomes and recurrence after treatment is often limited, especially for topical use.


Q: Does Tructum interact with common over-the-counter pain relievers?

A: Official information indicates that Tructum can affect how the body processes certain medications. For example, some OTC pain relievers, such as acetaminophen, may be associated with an increased risk of liver injury when combined with Tructum. It is generally recommended to confirm the safety of combining Tructum with all other medicines, including over-the-counter products, with a healthcare professional.


Q: Can Tructum be crushed or split if it's a pill?

A: Limited data indicates that the oral tablet is intended to be taken whole, as directed. The regulatory information describes that the integrity of the tablet is important, as altering the form may affect the absorption of the drug.


Q: Are there different brand names for the medicine Tructum?

A: Yes, Tructum is a product name, but its active ingredient is Ketoconazole, which is available under multiple brand names globally. Examples of other products containing Ketoconazole include Nizoral and Xolegel.


Q: Is there a generic version of Tructum available?

A: Yes, the active ingredient in Tructum, Ketoconazole, is available in generic versions. Additionally, lower-strength topical forms of the medication are often available without needing a prescription.


Q: Is Tructum approved in other countries besides the US?

A: Yes, the active ingredient in Tructum (Ketoconazole) has had regulatory approval and market status in countries outside of the US, including those under the European Medicines Agency (EMA) and other global authorities.


Q: How often do people need follow-up appointments when taking Tructum?

A: Patients using the Trastuzumab form of Tructum are subject to close medical monitoring due to the risk of cardiotoxicity (heart damage). Official labels describe a careful cardiac assessment and LVEF monitoring (a measure of heart function) to be performed at regular intervals during the course of treatment, typically every 3 months.


Q: How is the safety of Tructum monitored after it's approved?

A: The safety profile is continually monitored by regulatory agencies through pharmacovigilance programs after the medicine is approved. This ongoing surveillance has sometimes led to updated safety warnings, such as the FDA adding a Boxed Warning for the oral form and restricting its use.


Q: What is the typical timeframe before noticing the full effect of Tructum?

A: For topical treatment of fungal skin infections, clinical trials often run for 2 to 6 weeks, which is the timeframe typically described for full clinical clearing. The full recommended duration is typically advised to support the intended therapeutic effect.


Q: Why do doctors prefer Tructum over a similar drug in certain situations?

A: Official regulatory guidance indicates that, due to the risk of serious side effects, the oral form is intended for use when other effective antifungal therapies are unavailable or not tolerated. This reflects a risk-based assessment that determines when its use is appropriate.


Q: How can I tell if Tructum is not agreeing with me?

A: Official product information emphasizes that patients should be aware of serious side effects, particularly signs of liver injury. If symptoms associated with serious side effects, such as signs of liver injury (extreme tiredness, yellowing of the skin or eyes, dark urine), are experienced, medical attention may be sought immediately.


Q: Why is Tructum important for treating [treated condition]?

A: The importance of Tructum (Ketoconazole) stems from its function as a potent antifungal agent. By disrupting the fungal cell membrane, it either kills the fungus or stops its growth, which is necessary to help clear the infection and resolve the underlying physiological imbalance caused by the invading organism.

How should Tructum be stored and disposed of?

How to Store and Dispose of Tructum?

Regulatory documentation mandates precise conditions for the storage and disposal of Tructum (Ketoconazole) to maintain its stability.

Requirement Details
Storage Temperature Must be stored at Controlled Room Temperature, between 15 C to 30 C (59 F to 86 F).
Protection and Container Tablets must be protected from moisture and dispensed in a tight, light-resistant container that is kept tightly closed.
Child Safety Keep out of reach of children for all formulations.
Special Handling The topical gel is flammable; avoid fire, flame, or smoking during and immediately following application.
Disposal Unused or expired Tructum must be properly disposed of according to official labeling or community drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tructum found in:

A-Z Index: